文献速递其他结缔组织病

IL-31促进硬皮病皮肤与肺纤维化致病机制

Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究探讨Th2细胞因子IL-31及其受体IL-31RA在硬皮病皮肤和肺纤维化中的作用。部分硬皮病患者血浆及纤维化皮损和肺组织中IL-31水平升高,皮肤和肺成纤维细胞因miR326表观调控缺失而过表达IL-31RA。IL-31通过pSTAT3诱导成纤维细胞迁移和胶原释放,并在小鼠中诱导皮肤和肺纤维化,提示IL-31/IL-31RA是候选促纤维化通路。

要点

  • 部分硬皮病患者血浆及纤维化皮肤、肺组织中IL-31水平升高。
  • 皮肤和肺成纤维细胞因miR326表观调控缺失而过表达IL-31RA。
  • IL-31通过pSTAT3促进成纤维细胞迁移和胶原释放,诱导小鼠皮肤和肺纤维化。

核心结论

  • IL-31/IL-31RA被证实为候选促纤维化通路,可能参与部分硬皮病患者的皮肤和肺纤维化。

研究设计与样本

  • 检测硬皮病患者血浆IL-31及纤维化皮肤和肺组织的免疫组化,qPCR检测组织驻留细胞IL-31RA。
  • 用下一代测序分析正常皮肤成纤维细胞对IL-31的应答。
  • 在野生型Balb/c小鼠中经皮下微型泵给予IL-31,伴或不伴TGFβ,通过组织学和血浆ELISA评估纤维化反应。

主要发现

  • 部分硬皮病患者血浆及纤维化皮肤和肺病灶中IL-31呈高水平。
  • 皮肤和肺成纤维细胞等下游细胞因miR326表观调控缺失而过表达IL-31RA。
  • IL-31诱导皮肤成纤维细胞与细胞生长增殖、厌氧代谢和矿化相关的测序谱,负向关联血管生成和血管修复。
  • IL-31通过pSTAT3促进成纤维细胞迁移和胶原蛋白释放等表型改变。
  • 小鼠中IL-31诱导皮肤和肺纤维化,与TGFβ未见协同作用,TGFβ抑制IL-31RA。

临床怎么用

  • IL-31/IL-31RA通路可作为部分硬皮病患者皮肤和肺纤维化的候选干预靶点。
  • 检测IL-31水平或IL-31RA表达可能有助于识别促纤维化通路活跃的硬皮病亚群。

局限性

  • IL-31高水平仅见于部分硬皮病患者,结论不能推广至所有硬皮病患者。
  • 小鼠实验不能完全代表人类硬皮病纤维化过程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cytokines released by infiltrating T cells may promote mechanisms leading to fibrosis in scleroderma. The aim of this study was to investigate the role of the Th2 cytokine IL-31, and its receptor IL-31RA, in scleroderma skin and lung fibrosis. METHODS: IL-31 was measured by ELISA of plasma, and by immunochemistry of fibrotic skin and lung tissue of scleroderma patients. The receptor, IL-31RA, was assayed by qPCR of tissue resident cells. Next-generation sequencing was used to profile the responses of normal skin fibroblasts to IL-31. In wild-type Balb/c mice, IL-31 was administered by subcutaneous mini pump, with or without additional TGFβ, and the fibrotic reaction measured by histology and ELISA of plasma. RESULTS: IL-31 was present at high levels in plasma and fibrotic skin and lung lesions in a subset of scleroderma patients, and the receptor overexpressed by downstream cells relevant to the disease process, including skin and lung fibroblasts, through loss of epigenetic regulation by miR326. In skin fibroblasts, IL-31 induced next generation sequencing profiles associated with cellular growth and proliferation, anaerobic metabolism and mineralization, and negatively associated with angiogenesis and vascular repair, as well as promoting phenotype changes including migration and collagen protein release via pSTAT3, resembling the activation state in the disease. In mice, IL-31 induced skin and lung fibrosis. No synergy was seen with TGFβ, which supressed IL-31RA. CONCLUSION: IL-31/IL-31RA is confirmed as a candidate pro-fibrotic pathway, which may contribute to skin and lung fibrosis in a subset of scleroderma patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yaseen B, Lopez H, Taki Z, et al. Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma. Rheumatology (Oxford). 2020. PMID: 32365362. doi:10.1093/rheumatology/keaa195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。